norethindrone has been researched along with leuprolide in 22 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (4.55) | 18.7374 |
1990's | 13 (59.09) | 18.2507 |
2000's | 3 (13.64) | 29.6817 |
2010's | 5 (22.73) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Judd, HL; Surrey, ES | 1 |
Barbieri, RL | 1 |
Asch, RH; Balmaceda, JP; Borrero, C; Gerli, S; Partrizio, P; Remohi, J; Silber, SJ | 1 |
Paskowitz, RA | 1 |
Anania, C; Elkind-Hirsch, KE; Mack, M; Malinak, R | 1 |
Daly, M; Friedman, AJ; Gleason, R; Juneau-Norcross, M; LeBoff, M; Rein, MS | 1 |
Asch, RH; Balmaceda, JP; Ciuffardi, I; Frederick, JL; Gonzalez, P; Maloul, S | 1 |
Fournet, N; Judd, HL; Surrey, ES; Voigt, B | 2 |
Ditkoff, EC; Levin, JH; Lobo, RA; Paul, WL | 1 |
Ditkoff, EC; Sauer, MV | 1 |
Ditkoff, EC; Lindheim, S; Prosser, R; Sauer, MV; Zimmermann, RC | 1 |
Casino, LA; Hornstein, MD; Surrey, ES; Weisberg, GW | 1 |
Marik, JJ | 1 |
Hornstein, MD; Surrey, ES | 1 |
Divasta, AD; Gordon, CM; Laufer, MR | 1 |
Atabey, N; Dogan, E; Kizildag, S; Koyuncuoglu, M; Posaci, C; Saatli, B; Ulukus, EC | 1 |
Brook, RA; Chwalisz, K; Fuldeore, MJ; Marx, SE; Smeeding, JE | 1 |
DiVasta, AD; Feldman, HA; Gordon, CM; Hornstein, MD; Laufer, MR; Sadler Gallagher, J; Stokes, NA | 1 |
Bonafede, M; Castelli-Haley, J; Farr, AM; Soliman, AM; Winkel, C | 1 |
DiVasta, AD; Gallagher, JS; Gordon, CM; Hornstein, MD; Laufer, MR; Missmer, SA | 1 |
Edelman, A; Han, L; Hart, KD; Jensen, JT; Padua, E | 1 |
11 trial(s) available for norethindrone and leuprolide
Article | Year |
---|---|
Reduction of vasomotor symptoms and bone mineral density loss with combined norethindrone and long-acting gonadotropin-releasing hormone agonist therapy of symptomatic endometriosis: a prospective randomized trial.
Topics: Bone Density; Drug Combinations; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Laparoscopy; Leuprolide; Lumbosacral Region; Norethindrone; Pain; Prospective Studies; Spine; Vasomotor System | 1992 |
Combination gonadotropin-releasing hormone agonist and oral contraceptive therapy improves treatment of hirsute women with ovarian hyperandrogenism.
Topics: Adolescent; Adult; Contraceptives, Oral; Drug Therapy, Combination; Endometrium; Ethinyl Estradiol; Female; Hirsutism; Humans; Hyperandrogenism; Leuprolide; Luteinizing Hormone; Norethindrone; Ovarian Diseases; Testosterone | 1995 |
Long-term medical therapy for leiomyomata uteri: a prospective, randomized study of leuprolide acetate depot plus either oestrogen-progestin or progestin 'add-back' for 2 years.
Topics: Adult; Bone Density; Cholesterol, HDL; Delayed-Action Preparations; Estradiol Congeners; Estrone; Female; Hematocrit; Humans; Leiomyoma; Leuprolide; Middle Aged; Norethindrone; Prospective Studies; Time Factors; Uterine Neoplasms | 1994 |
The use of progestins for programming assisted reproductive cycles and gonadotropin-releasing hormone agonist flare-up protocols in older patients.
Topics: Adult; Aging; Estradiol; Female; Follicle Stimulating Hormone; Humans; Leuprolide; Luteinizing Hormone; Middle Aged; Norethindrone; Norethindrone Acetate; Pregnancy; Reproductive Techniques; Retrospective Studies | 1995 |
Prolonged gonadotropin-releasing hormone agonist treatment of symptomatic endometriosis: the role of cyclic sodium etidronate and low-dose norethindrone "add-back" therapy.
Topics: Adult; Bone Density; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Endometriosis; Estradiol; Etidronic Acid; Female; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Lipids; Norethindrone; Prospective Studies; Time Factors; Vasomotor System; Weight Gain | 1995 |
Effects of sodium etidronate in combination with low-dose norethindrone in patients administered a long-acting GnRH agonist: a preliminary report.
Topics: Bone Density; Bone Resorption; Drug Therapy, Combination; Endometriosis; Estrogens; Etidronic Acid; Female; Humans; Leuprolide; Lipids; Norethindrone; Prospective Studies; Vasomotor System | 1993 |
A combination of norethindrone acetate and leuprolide acetate blocks the gonadotrophin-releasing hormone agonistic response and minimizes cyst formation during ovarian stimulation.
Topics: Adult; Chorionic Gonadotropin; Drug Therapy, Combination; Estradiol; Female; Fertilization in Vitro; Humans; Leuprolide; Menotropins; Norethindrone; Norethindrone Acetate; Ovarian Cysts; Ovulation Induction; Pregnancy; Prospective Studies | 1996 |
Leuprolide acetate depot and hormonal add-back in endometriosis: a 12-month study. Lupron Add-Back Study Group.
Topics: Adult; Bone Density; Cohort Studies; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Endometriosis; Equilin; Estradiol; Female; Gonadotropin-Releasing Hormone; Humans; Injections, Intramuscular; Leuprolide; Lipid Metabolism; Lipids; Lumbar Vertebrae; Norethindrone; Pain Measurement; Patient Dropouts; Pelvic Pain; Progesterone Congeners; Vasomotor System | 1998 |
Prolonged GnRH agonist and add-back therapy for symptomatic endometriosis: long-term follow-up.
Topics: Adult; Bone Density; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Endometriosis; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Norethindrone; Norethindrone Acetate; Patient Dropouts; Prospective Studies | 2002 |
The Effects of Gonadotropin-Releasing Hormone Agonist Combined with Add-Back Therapy on Quality of Life for Adolescents with Endometriosis: A Randomized Controlled Trial.
Topics: Adolescent; Boston; Contraceptives, Oral, Synthetic; Double-Blind Method; Drug Therapy, Combination; Endometriosis; Estrogens; Estrogens, Conjugated (USP); Female; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Norethindrone; Norethindrone Acetate; Pain; Quality of Life; Treatment Outcome; Young Adult | 2017 |
Long-Term Effects of Gonadotropin-Releasing Hormone Agonists and Add-Back in Adolescent Endometriosis.
Topics: Adolescent; Boston; Endometriosis; Estrogens, Conjugated (USP); Female; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Longitudinal Studies; Norethindrone; Surveys and Questionnaires; Young Adult | 2018 |
11 other study(ies) available for norethindrone and leuprolide
Article | Year |
---|---|
Gonadotropin-releasing hormone agonists and estrogen-progestogen replacement therapy.
Topics: Drug Therapy, Combination; Endometriosis; Estrogen Replacement Therapy; Female; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Leuprolide; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Uterine Neoplasms | 1990 |
Programming of ovarian stimulation with norethindrone acetate in IVF/GIFT cycles.
Topics: Adult; Female; Fertilization in Vitro; Follicle Stimulating Hormone; Gamete Intrafallopian Transfer; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Menotropins; Norethindrone; Ovulation; Ovulation Induction | 1989 |
"Rollerball" ablation of the endometrium.
Topics: Electrocoagulation; Endometrium; Female; Humans; Hysterectomy; Leuprolide; Life Tables; Medroxyprogesterone Acetate; Menorrhagia; Norethindrone; Norethindrone Acetate; Postoperative Complications; Reoperation; Uterine Hemorrhage | 1995 |
Time-resolved fluoroimmunoassay compared with radioimmunoassay of luteinizing hormone.
Topics: Adult; Evaluation Studies as Topic; Female; Fluoroimmunoassay; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Luteinizing Hormone; Norethindrone; Polycystic Ovary Syndrome; Pulsatile Flow; Radioimmunoassay; Reference Values; Time Factors | 1993 |
The addition of norethindrone acetate to leuprolide acetate for ovarian suppression has no adverse effect on ovarian stimulation.
Topics: Adult; Blastomeres; Drug Therapy, Combination; Female; Fertilization in Vitro; Follicular Phase; Humans; Leuprolide; Menotropins; Norethindrone; Norethindrone Acetate; Oocytes; Ovulation Induction; Pregnancy; Progesterone Congeners; Superovulation | 1997 |
Leuprolide acetate depot and hormonal add-back in endometriosis: a 12-month study.
Topics: Drug Therapy, Combination; Endometriosis; Estrogens, Conjugated (USP); Female; Humans; Leuprolide; Norethindrone; Norethindrone Acetate | 1998 |
Bone density in adolescents treated with a GnRH agonist and add-back therapy for endometriosis.
Topics: Absorptiometry, Photon; Adolescent; Adult; Bone Density; Cohort Studies; Endometriosis; Female; Gonadotropin-Releasing Hormone; Hip; Humans; Leuprolide; Lumbar Vertebrae; Norethindrone; Norethindrone Acetate | 2007 |
Long-term effects of GnRH agonist, GnRH antagonist, and estrogen plus progesterone treatment on apoptosis related genes in rat ovary.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Estradiol; Estrogens; Female; Gonadotropin-Releasing Hormone; Leuprolide; Norethindrone; Ovary; Progesterone; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction | 2009 |
Add-back therapy use and its impact on LA persistence in patients with endometriosis.
Topics: Adult; Contraceptives, Oral, Synthetic; Databases, Factual; Endometriosis; Estrogens; Female; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Middle Aged; Norethindrone; Norethindrone Acetate; Patient Compliance; Progesterone Congeners; Retrospective Studies | 2010 |
Analysis of Adherence, Persistence, and Surgery Among Endometriosis Patients Treated with Leuprolide Acetate Plus Norethindrone Acetate Add-Back Therapy.
Topics: Adult; Bone Density; Drug Therapy, Combination; Endometriosis; Estrogens; Female; Gonadotropin-Releasing Hormone; Humans; International Classification of Diseases; Leuprolide; Medication Adherence; Norethindrone; Norethindrone Acetate; Retrospective Studies | 2016 |
Comparing cervical mucus changes in response to an oral progestin or oestrogen withdrawal in ovarian-suppressed women: a clinical pilot.
Topics: Adult; Cervix Mucus; Cervix Uteri; Contraceptives, Oral, Hormonal; Cross-Over Studies; Estradiol; Female; Fertility Agents, Female; Humans; Leuprolide; Mucus; Norethindrone; Pilot Projects; Progesterone; Progestins; Transdermal Patch; Young Adult | 2019 |